Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland
Macdonald C. et al, (2024), npj Vaccines, 9
Correction to: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England (Nature Communications, (2024), 15, 1, (3822), 10.1038/s41467-024-47745-z)
Copland E. et al, (2024), Nature Communications, 15
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Gu X. et al, (2024), npj Vaccines, 9
Deploying an asthma dashboard to support quality improvement across a nationally representative sentinel network of 7.6 million people in England
Mukherjee M. et al, (2024), npj Primary Care Respiratory Medicine, 34
Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
Ward IL. et al, (2024), Nature Communications, 15
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Copland E. et al, (2024), Nature Communications, 15
The UK Soft Drinks Industry Levy and childhood hospital admissions for asthma in England
Rogers NT. et al, (2024), Nature Communications, 15
Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts
Aldridge SJ. et al, (2024), Nature Communications, 15
Waiting list models must account for departures before treatment – Authors' reply
Shah SA. et al, (2024), The Lancet, 404, 432 - 433
Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database
Mukherjee M. et al, (2024), The Lancet Regional Health - Europe, 42
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, e417 - e418
Development and validation of a new algorithm for improved cardiovascular risk prediction
Hippisley-Cox J. et al, (2024), Nature Medicine, 30, 1440 - 1447
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
Tsang RSM. et al, (2024), Journal of the Royal Society of Medicine, 117, 134 - 148
Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.
Papadopoulos NG. et al, (2024), Pediatr Allergy Immunol, 35
Setting research priorities for global pandemic preparedness: An international consensus and comparison with ChatGPT's output.
Song P. et al, (2024), J Glob Health, 14
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
Kerr S. et al, (2024), The Lancet, 403, 554 - 566
Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic: A cohort study of 23.5 million people in England
Green MA. et al, (2024), BMJ Open, 14
Lessons from the English primary care sentinel network's response to the COVID-19 pandemic
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, 14 - 16